616402 TACE Substrate II, Fluorogenic
Recommended Products
Overview
| Replacement Information |
|---|
| References | |
|---|---|
| References | Patel, I.R., et al. 1998. J. Immunol. 160, 4570. Van Dyk, D.E., et al. 1997. Bioorg. Med. Chem. Lett. 7, 1219. |
| Product Information | |
|---|---|
| Form | Liquid |
| Formulation | A 4 mM (7.5 mg/ml) solution in DMSO. |
| Hill Formula | C₆₉H₁₀₃N₂₃O₂₄ |
| Chemical formula | C₆₉H₁₀₃N₂₃O₂₄ |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥90% by HPLC |
| Physicochemical Information | |
|---|---|
| Peptide Sequence | MCA-Pro-Leu-Ala-Gln-Ala-Val-Dpa-Arg-Ser-Ser-Ser-Arg-NH₂[Dpa = N-3-(2,4-Dinitrophenyl)-L-2,3-diaminopropionyl] |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 616402 | 0 |
Documentation
References
| Reference overview |
|---|
| Patel, I.R., et al. 1998. J. Immunol. 160, 4570. Van Dyk, D.E., et al. 1997. Bioorg. Med. Chem. Lett. 7, 1219. |


